ResMed News

Aktie
WKN:  895878 ISIN:  US7611521078 US-Symbol:  RMD Branche:  Gesundheitswesen: Ausstattung u. Produkte Land:  USA
215,85 €
-1,05 €
-0,48%
10:58:53 Uhr
Depot/Watchlist
Marktkapitalisierung *
30,44 Mrd. €
Streubesitz
33,73%
KGV
27,07
Dividende
2,01 EUR
Dividendenrendite
0,98%
Nachhaltigkeits-Score
51 %
Index-Zuordnung
S&P 500
Weiter abwärts? Short handeln - Jetzt mit Hebel 6,33: MJ286A
Werbung

ResMed News

03.09.25 - GlobeNewswire
Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority
New global clinical insights initiative debuts at World Sleep Congress 2025 to help drive innovation in sleep health care
27.08.25 - GlobeNewswire
Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds
Published in The Lancet Respiratory Medicine, research reveals sharp rise in OSA, especially among women, highlighting the need for earlier diagnosis, preventative strategies, ...
21.08.25 - GlobeNewswire
Resmed Strengthens Innovation Leadership with Dual Red Dot Design Awards and 10,000 Patents and Designs
Milestones underscore Resmed’s leadership and commitment to delivering life-​changing health technology that people love
18.08.25 - GlobeNewswire
Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio
Mowad-​Nassar is Senior Vice President at AbbVie and President, Specialty and U.S. Therapeutics Operations Her appointment brings over 30 years of strategic, commercial, and ...
15.05.25 - GlobeNewswire
Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025
SAN DIEGO and LONDON and DUBLIN and SYDNEY, May 15, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on ...
01.05.25 - GlobeNewswire
Resmed Acquires VirtuOx
Acquisition supports Resmed’s growth in virtual care, expands access to diagnosis, and enhances the digital experience for patients and providers
21.04.25 - GlobeNewswire
Resmed Names Salli Schwartz as Chief Investor Relations Officer
Former Illumina, MSCI, and Moody’s executive brings extensive experience leading engagement with the global investment community
19.03.25 - GlobeNewswire
New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer
Largest ever meta-​analysis on the long-term benefits of CPAP therapy, published in The Lancet Respiratory Medicine, found that in people with sleep apnea, CPAP therapy lowered ...
11.03.25 - GlobeNewswire
Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution
Brand Evolution Unites Brands Under One Resmed Identity to Make Better Sleep and Breathing Health More Accessible to Everyone

Newssuche

Videos

newspaper
25.02.26
So beeinflussen Margins DEIN Trading
Börsentäglich ab 18 Uhr Feierabend-​Trading Live. Teilnahme kostenlos mit diesem Link ... Mehr »